World's Best Scientists 2026 revealed!
Award Badge
Biology and Biochemistry
UAE
2026

D-Index & Metrics

Biology and Biochemistry

D-Index
55
Citations
18332
World Ranking
14783
National Ranking
3

Mohamed Rahmani publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Mohamed Rahmani sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 105 publications — 7th percentile

7% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Mohamed Rahmani D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Mohamed Rahmani sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 55 D-Index — 25th percentile

25% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Biology and Biochemistry in United Arab Emirates Leader Award
  • 2025 - Research.com Biology and Biochemistry in United Arab Emirates Leader Award

Overview

Mohamed Rahmani is affiliated with Khalifa University in the United Arab Emirates. Their research spans multiple areas within medicine and biochemistry, genetics, and molecular biology, with a notable focus on molecular biology and oncology. They have contributed extensively to fields such as infectious diseases, cancer research, and hematology.

Their work covers several main topics, including:

  • Protein Degradation and Inhibitors
  • COVID-19 Clinical Research Studies
  • Cancer, Hypoxia, and Metabolism
  • Cancer Cells and Metastasis
  • HER2/EGFR in Cancer Research
  • Cell death mechanisms and regulation
  • RNA Interference and Gene Delivery

Rahmani's research output includes publications in the following venues:

  • Frontiers in Immunology
  • Cancers
  • Clinical Cancer Research
  • Scientific Reports
  • Journal of Molecular Medicine

Frequent co-authors collaborating with Rahmani include:

  • Rifat Hamoudi
  • Sarah Hammoudeh
  • Thenmozhi Venkatachalam
  • Arabella Musa Hammoudeh
  • Bassam Mahboub

Notable recent papers authored by Rahmani present a range of research foci and were published between 2021 and 2024:

  • "Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives," 2021, Cancers
  • "Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients," 2021, Frontiers in Immunology
  • "Insight into molecular mechanisms underlying hepatic dysfunction in severe COVID-19 patients using systems biology," 2021, World Journal of Gastroenterology
  • "Dual mTORC1/2 Inhibition Synergistically Enhances AML Cell Death in Combination with the BCL2 Antagonist Venetoclax," 2023, Clinical Cancer Research
  • "1H-NMR metabolomics analysis identifies hypoxanthine as a novel metastasis-associated metabolite in breast cancer," 2024, Scientific Reports

Rahmani's scientific contributions cover critical areas including cell death mechanisms and regulation, as well as cancer metabolism and the immunopathogenesis of infectious diseases such as COVID-19. Their interdisciplinary approach integrates molecular biology techniques with clinical research studies, reflecting a broad engagement with both fundamental and translational research questions.

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Apoptosis Induced by the Kinase Inhibitor BAY 43-9006 in Human Leukemia Cells Involves Down-regulation of Mcl-1 through Inhibition of Translation

    Mohamed Rahmani;Eric Maynard Davis;Cheryl Bauer;Paul Dent

  • The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571.

    Chunrong Yu;Mohamed Rahmani;Daniel Conrad;Mark Subler

  • Blockade of Histone Deacetylase Inhibitor-Induced RelA/p65 Acetylation and NF-κB Activation Potentiates Apoptosis in Leukemia Cells through a Process Mediated by Oxidative Damage, XIAP Downregulation, and c-Jun N-Terminal Kinase 1 Activation

    Yun Dai;Mohamed Rahmani;Paul Dent;Steven Grant

  • A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia

    Steven W. Paugh;Barbara S. Paugh;Mohamed Rahmani;Dmitri Kapitonov

  • A Bcr/Abl-independent, Lyn-dependent Form of Imatinib Mesylate (STI-571) Resistance Is Associated with Altered Expression of Bcl-2

    Yun Dai;Mohamed Rahmani;Seth J. Corey;Paul Dent

  • Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species.

    Mohamed Rahmani;Erin Reese;Yun Dai;Cheryl Bauer

  • Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.

    Chunrong Yu;Geoffrey Krystal;Lyuba Varticovksi;Robert McKinstry

  • The kinase inhibitor sorafenib induces cell death through a process involving induction of endoplasmic reticulum stress.

    Mohamed Rahmani;Eric Maynard Davis;Timothy Ryan Crabtree;Joseph Reza Habibi

  • Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Targeting Mcl-1 for the therapy of cancer

    Bridget A Quinn;Rupesh Dash;Belal Azab;Siddik Sarkar

  • Coadministration of the heat shock protein 90 antagonist 17-allylamino- 17-demethoxygeldanamycin with suberoylanilide hydroxamic acid or sodium butyrate synergistically induces apoptosis in human leukemia cells.

    Mohamed Rahmani;Chunrong Yu;Yun Dai;Erin Reese

  • Histone Deacetylase Inhibitors Promote STI571-mediated Apoptosis in STI571-sensitive and -resistant Bcr/Abl+ Human Myeloid Leukemia Cells

    Chunrong Yu;Mohamed Rahmani;Jorge Almenara;Mark Subler

  • Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation

    Margaret A. Park;Guo Zhang;Aditi Pandya Martin;Hossein Hamed

  • The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor Bortezomib

    Chunrong Yu;Mohamed Rahmani;Paul Dent;Steven Grant

  • Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-κB-dependent process

    Yun Dai;Mohamed Rahmani;Steven Grant

  • The Histone Deacetylase Inhibitor MS-275 Interacts Synergistically with Fludarabine to Induce Apoptosis in Human Leukemia Cells

    Sonia C. Maggio;Roberto R. Rosato;Lora B. Kramer;Yun Dai

  • Bortezomib and flavopiridol interact synergistically to induce apoptosis in chronic myeloid leukemia cells resistant to imatinib mesylate through both Bcr/Abl-dependent and -independent mechanisms

    Yun Dai;Mohamed Rahmani;Xin-Yan Pei;Paul Dent

  • Dual Inhibition of Bcl-2 and Bcl-xL Strikingly Enhances PI3K Inhibition-Induced Apoptosis in Human Myeloid Leukemia Cells through a GSK3- and Bim-Dependent Mechanism

    Mohamed Rahmani;Mandy Mayo Aust;Elisa Attkisson;David C. Williams

Frequent Co-Authors

Steven Grant
Steven Grant Virginia Commonwealth University
Paul Dent
Paul Dent Virginia Commonwealth University
Paul B. Fisher
Paul B. Fisher Virginia Commonwealth University
Rifat Hamoudi
Rifat Hamoudi University of Sharjah
Qutayba Hamid
Qutayba Hamid University of Sharjah
David T. Curiel
David T. Curiel Washington University in St. Louis
Evelina Gatti
Evelina Gatti Aix-Marseille University
Devanand Sarkar
Devanand Sarkar Virginia Commonwealth University
Sujit K. Bhutia
Sujit K. Bhutia National Institute of Technology Rourkela
Beth Levine
Beth Levine The University of Texas Southwestern Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry in the USA can open doors to many related fields and online degree opportunities. If you're interested in food science and wellness, consider an online nutritionist degree. This path combines biology fundamentals with practical skills for a career in nutrition or dietetics.

Many students in the life sciences transition to healthcare roles. Nurses looking to advance their careers can benefit from the best online rn to bsn programs, which build on a biology background and offer flexibility for working professionals.

If you’re more interested in management and leadership, an online masters healthcare management program can help you pivot into administrative or leadership roles in medical or research settings.

For those drawn to mental health, advanced nursing programs such as psych np programs allow biology graduates to become specialized nurse practitioners in psychiatric care, meeting a growing demand in mental health services.

Best Scientists Citing Mohamed Rahmani

Trending Scientists

Recently Published Articles